Bml Capital Management, LLC Top Holdings and 13F Report (2025) About Bml Capital Management, LLCInvestment ActivityBml Capital Management, LLC has $160.97 million in total holdings as of December 31, 2024.Bml Capital Management, LLC owns shares of 25 different stocks, but just 9 companies or ETFs make up 80% of its holdings.Approximately 14.46% of the portfolio was purchased this quarter.About 21.32% of the portfolio was sold this quarter.This quarter, Bml Capital Management, LLC has purchased 29 new stocks and bought additional shares in 7 stocks.Bml Capital Management, LLC sold shares of 5 stocks and completely divested from 8 stocks this quarter.Largest Holdings Aclaris Therapeutics $35,340,000iShares 0-3 Month Treasury Bond ETF $26,083,200Atea Pharmaceuticals $25,487,845ADVERUM BIOTECHNOLOGIES INC $10,591,859(ANTX) $7,934,216 Largest New Holdings this Quarter ESSA Pharma $7,556,567 HoldingAthira Pharma $1,628,612 HoldingPALVELLA THERAPEUTICS INC NE $505,560 HoldingKEZAR LIFE SCIENCES INC $327,049 Holding Largest Purchases this Quarter ESSA Pharma 4,221,546 shares (about $7.56M)Ikena Oncology 2,862,578 shares (about $4.69M)Atea Pharmaceuticals 958,312 shares (about $3.21M)PMV Pharmaceuticals 1,777,912 shares (about $2.68M)Athira Pharma 2,775,885 shares (about $1.63M) Largest Sales this Quarter LENZ THERAPEUTICS INC 50,729 shares (about $1.46M)iShares 0-3 Month Treasury Bond ETF 10,000 shares (about $1.00M)AlloVir 418,840 shares (about $175.91K)Verrica Pharmaceuticals 5,349 shares (about $3.74K)NextCure 2,929 shares (about $2.26K) Sector Allocation Over TimeMap of 500 Largest Holdings ofBml Capital Management, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorACRSAclaris Therapeutics$35,340,0000.0%14,250,00022.0%MedicalSGOViShares 0-3 Month Treasury Bond ETF$26,083,200$1,003,200 ▼-3.7%260,00016.2%ETFAVIRAtea Pharmaceuticals$25,487,845$3,210,345 ▲14.4%7,608,31215.8%MedicalADVERUM BIOTECHNOLOGIES INC$10,591,8590.0%2,268,0646.6%COM NEWANTX(ANTX)$7,934,2160.0%5,749,4324.9%MedicalINSTIL BIO INC$7,636,000$1,240,850 ▲19.4%400,0004.7%COM NEWEPIXESSA Pharma$7,556,567$7,556,567 ▲New Holding4,221,5464.7%MedicalAADIAadi Bioscience$6,625,500$315,500 ▲5.0%2,100,0004.1%MedicalORMPOramed Pharmaceuticals$6,398,255$1,107,673 ▲20.9%2,643,9074.0%MedicalIKNAIkena Oncology$5,880,820$4,694,628 ▲395.8%3,585,8663.7%MedicalPMVPPMV Pharmaceuticals$5,234,693$2,684,647 ▲105.3%3,466,6843.3%MedicalACHLAchilles Therapeutics$4,674,0020.0%4,100,0022.9%MedicalCNTBConnect Biopharma$2,888,6600.0%2,093,2321.8%MedicalMISTMilestone Pharmaceuticals$2,681,1750.0%1,136,0911.7%MedicalATHAAthira Pharma$1,628,612$1,628,612 ▲New Holding2,775,8851.0%MedicalASTCAstrotech$1,481,1550.0%220,4100.9%AerospaceLSTALisata Therapeutics$848,3140.0%284,6690.5%MedicalPALVELLA THERAPEUTICS INC NE$505,560$505,560 ▲New Holding42,1300.3%COMVTGNVistagen Therapeutics$442,5000.0%150,0000.3%MedicalKEZAR LIFE SCIENCES INC$327,049$327,049 ▲New Holding48,6680.2%COM NEWLENZ THERAPEUTICS INC$267,654$1,464,547 ▼-84.5%9,2710.2%COMNXTCNextCure$210,896$2,258 ▼-1.1%273,5360.1%MedicalVRCAVerrica Pharmaceuticals$122,256$3,744 ▼-3.0%174,6510.1%MedicalALVRAlloVir$77,383$175,912 ▼-69.4%184,2460.0%MedicalHLVXHilleVax$42,973$2,070 ▲5.1%20,7600.0%MedicalBILSPDR Bloomberg Barclays 1-3 Month T-Bill ETF$0$16,066,750 ▼-100.0%00.0%ETFTECTONIC THERAPEUTIC INC$0$6,416,086 ▼-100.0%00.0%COMRPHMReneo Pharmaceuticals$0$5,877,572 ▼-100.0%00.0%MedicalVNDAVanda Pharmaceuticals$0$1,071,665 ▼-100.0%00.0%MedicalPIERIS PHARMACEUTICALS INC$0$698,515 ▼-100.0%00.0%COM NEWCALCCalciMedica$0$681,719 ▼-100.0%00.0%MedicalTLISTalis Biomedical$0$460,099 ▼-100.0%00.0%MedicalFORTE BIOSCIENCES INC$0$393,916 ▼-100.0%00.0%COM NEWShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
